Broad therapeutic treatment window of [Nle(4), D-Phe(7)]alpha-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils

European Journal of Pharmacology
Daniela GiulianiS Guarini

Abstract

Melanocortin peptides have been shown to produce neuroprotection in experimental ischemic stroke. The aim of the present investigation was to identify the therapeutic treatment window of melanocortins, and to determine whether these neuropeptides chronically protect against damage consequent to brain ischemia. A 10-min period of global cerebral ischemia in gerbils, induced by occluding both common carotid arteries, caused impairment in spatial learning and memory (Morris test: four sessions from 4 to 67 days after the ischemic episode), associated with neuronal death in the hippocampus. Treatment with a nanomolar dose (340 microg/kg i.p., every 12 h for 11 days) of the melanocortin analog [Nle(4), D-Phe(7)]alpha-melanocyte-stimulating hormone (NDP-alpha-MSH), starting 3-18 h after the ischemic episode, reduced hippocampal damage with improvement in subsequent functional recovery. The protective effect was long-lasting (67 days, at least) with all schedules of NDP-alpha-MSH treatment; however, in the latest treated (18 h) gerbils, some spatial memory deficits were detected. Pharmacological blockade of melanocortin MC(4) receptors prevented the protective effects of NDP-alpha-MSH. Our findings indicate that, in conditions of brai...Continue Reading

References

Aug 1, 1982·Neurology·C M Fisher
Dec 14, 1995·The New England Journal of Medicine·UNKNOWN National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Mar 1, 1995·Stroke; a Journal of Cerebral Circulation·R P WiardB R Cooper
Oct 1, 1996·Current Opinion in Neurobiology·D W Choi
May 1, 1997·Stroke; a Journal of Cerebral Circulation·J A ClemensS P Little
Aug 1, 1997·British Journal of Pharmacology·S GuariniA Bertolini
Mar 14, 1998·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·B NiS M Paul
Oct 20, 1998·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·K FinkM A Moskowitz
Apr 22, 1999·Annals of Neurology·J B SchulzM A Moskowitz
Sep 28, 1999·Molecular Medicine Today·E Herlaar, Z Brown
Sep 7, 2000·The New England Journal of Medicine·T Brott, J Bogousslavsky
Oct 12, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·J E WikbergA Skottner
Apr 12, 2002·Brain Research. Developmental Brain Research·Frank R SharpRamon Bernabeu
Jun 28, 2002·Brain Research. Brain Research Reviews·Ronen R Leker, Esther Shohami
Aug 3, 2002·Stroke; a Journal of Cerebral Circulation·David J GladstoneUNKNOWN Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery
Aug 6, 2002·Nature Medicine·Andreas ArvidssonOlle Lindvall
Oct 9, 2002·Trends in Pharmacological Sciences·Stephen J Getting
Mar 8, 2003·Stroke; a Journal of Cerebral Circulation·Nicolás VilaAngel Chamorro
Jun 12, 2003·European Journal of Pharmacology·Miklos VecsernyesArpad Tosaki
Sep 11, 2003·Brain Research·Alessandra OttaniSusanna Genedani
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Chia-Yi KuanPasko Rakic
Dec 23, 2003·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Yubo RenThaddeus S Nowak
Mar 6, 2004·Pharmacological Reviews·Anna CataniaJames M Lipton
Mar 16, 2004·Lancet·Werner HackeUNKNOWN NINDS rt-PA Study Group Investigators
Apr 3, 2004·Stroke; a Journal of Cerebral Circulation·Anthony J WilliamsFrank C Tortella
Apr 28, 2004·Trends in Neurosciences·Matthias EndresMichael A Moskowitz
Dec 25, 2004·Neuroreport·Stefan SpulberMarianne Schultzberg
Jun 1, 2005·European Journal of Pharmacology·Shimon AmemiyaYasuo Katayama

❮ Previous
Next ❯

Citations

Mar 20, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Vineet C ChitravanshiHreday N Sapru
Aug 20, 2010·The Open Neurology Journal·Marco BacigaluppiDirk M Hermann
Nov 20, 2008·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Alessandra OttaniSalvatore Guarini
Jun 26, 2007·European Journal of Pharmacology·Daniela GiulianiSalvatore Guarini
Nov 26, 2010·Clinical Oral Implants Research·Mauricio G AraújoJan Lindhe
May 13, 2011·Clinical Oral Implants Research·Enzo De SantisNiklaus P Lang
Mar 25, 2008·Neuropeptides·Gang ChenHans Stødkilde-Jørgensen
Aug 12, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Anna V SavosKyra J Becker
Oct 1, 2011·Stroke; a Journal of Cerebral Circulation·Dannielle ZierathKyra Becker
Feb 6, 2017·Mediators of Inflammation·Lila CarnigliaMercedes Lasaga
Nov 3, 2010·British Journal of Pharmacology·Alessandra BittoFrancesco Squadrito
Jun 14, 2008·Trends in Neurosciences·Anna Catania

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.